Laurence Tam
Stock Analyst at Morgan Stanley
(3.05)
# 2,639
Out of 4,649 analysts
38
Total ratings
64%
Success rate
7.6%
Average return
Main Sectors:
Stocks Rated by Laurence Tam
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Maintained: Buy | $50.00 | $45.14 | +10.77% | 9 | Jul 9, 2026 | |
| HKG: 6821 Asymchem Laboratories (Tianjin) Co., Ltd. | Maintained: Hold | $120.00 | $114.40 | +4.90% | 1 | Apr 15, 2026 | |
| HKG: 2268 WuXi XDC Cayman Inc. | Maintained: Buy | $60.00 → $88.00 | $62.05 | +41.82% | 2 | Nov 21, 2025 | |
| HKG: 0570 China Traditional Chinese Medicine Holdings Co. Limited | Maintained: Sell | $1.60 | $1.41 | +13.48% | 7 | Oct 17, 2025 | |
| HKG: 1099 Sinopharm Group Co. Ltd. | Maintained: Buy | $25.00 → $22.50 | $16.70 | +34.73% | 4 | Aug 22, 2025 | |
| HKG: 3880 Medtide Inc. | Initiated Coverage: Hold | $38.00 | $21.64 | n/a | 1 | Aug 6, 2025 | |
| HKG: 0874 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | Maintained: Hold | $21.70 → $21.40 | $15.13 | n/a | 4 | Dec 23, 2024 | |
| HKG: 2607 Shanghai Pharmaceuticals Holding Co., Ltd | Maintained: Buy | $17.50 → $17.00 | $11.75 | n/a | 3 | Dec 23, 2024 | |
| HKG: 3320 China Resources Pharmaceutical Group Limited | Maintained: Buy | $7.80 → $7.50 | $4.85 | n/a | 3 | Sep 17, 2024 | |
| HKG: 9989 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | Maintained: Hold | $3.50 | $4.47 | n/a | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6.10 | $3.28 | n/a | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17.00 → $15.00 | $6.48 | n/a | 2 | Mar 15, 2024 |
WuXi Biologics (Cayman) Inc.
Jul 9, 2026
Maintained: Buy
Price Target: $50.00
Current: $45.14
Upside: +10.77%
Asymchem Laboratories (Tianjin) Co., Ltd.
Apr 15, 2026
Maintained: Hold
Price Target: $120.00
Current: $114.40
Upside: +4.90%
WuXi XDC Cayman Inc.
Nov 21, 2025
Maintained: Buy
Price Target: $60.00 → $88.00
Current: $62.05
Upside: +41.82%
China Traditional Chinese Medicine Holdings Co. Limited
Oct 17, 2025
Maintained: Sell
Price Target: $1.60
Current: $1.41
Upside: +13.48%
Sinopharm Group Co. Ltd.
Aug 22, 2025
Maintained: Buy
Price Target: $25.00 → $22.50
Current: $16.70
Upside: +34.73%
Medtide Inc.
Aug 6, 2025
Initiated Coverage: Hold
Price Target: $38.00
Current: $21.64
Upside: n/a
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Dec 23, 2024
Maintained: Hold
Price Target: $21.70 → $21.40
Current: $15.13
Upside: n/a
Shanghai Pharmaceuticals Holding Co., Ltd
Dec 23, 2024
Maintained: Buy
Price Target: $17.50 → $17.00
Current: $11.75
Upside: n/a
China Resources Pharmaceutical Group Limited
Sep 17, 2024
Maintained: Buy
Price Target: $7.80 → $7.50
Current: $4.85
Upside: n/a
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Sep 17, 2024
Maintained: Hold
Price Target: $3.50
Current: $4.47
Upside: n/a
Apr 17, 2024
Maintained: Hold
Price Target: $6.10
Current: $3.28
Upside: n/a
Mar 15, 2024
Maintained: Buy
Price Target: $17.00 → $15.00
Current: $6.48
Upside: n/a